Abstract:Background: Influenza A virus (IAV) infection poses a persistent global health challenge, necessitating a nuanced grasp of host immune responses for optimal interventions. While the interplay between aging, immunosenescence, and IAV is recognized as key in severe lower respiratory tract infections, the role of specific patient attributes in shaping innate immune reactions and inflammasome activity during IAV infection remains under-investigated. In this study, we utilized an ex vivo infection model of human lung tissues with H3N2 IAV to discern relationships among patient demographics, IAV nucleoprotein (NP) expression, toll-like receptor (TLR) profiles, PD-1/PD-L1 markers, and cytokine production. Methods: Our cohort consisted of thirty adult patients who underwent video-assisted thoracoscopic surgery during 2018–2019. Post-surgical lung tissues were exposed to H3N2 IAV for ex vivo infections, and the ensuing immune responses were profiled using flow cytometry. Results: We observed pronounced IAV activity within lung cells, as indicated by marked NP upregulation in both epithelial cells ( P = 0.022) and macrophages ( P = 0.003) in the IAV-exposed group relative to controls. Notably, interleukin-2 levels correlated with variations in TLR1 expression on epithelial cells and PD-L1 markers on macrophages. Age emerged as a modulating factor, dampening innate immune reactions, as evidenced by reduced interleukin-2 and interferon-γ concentrations (both adjusted P < 0.05). Intriguingly, a subset of participants with pronounced tumor necrosis factor-alpha post-mock infection (Cluster 1) showed attenuated cytokine responses in contrast to their counterparts in Cluster 2 and Cluster 3 (all adjusted P < 0.05). Individuals in Cluster 2, characterized by a low post-mock infection NP expression in macrophages, exhibited reduced variations in both NP and TLR1–3 expressions on these cells and a decreased variation in interleukin-2 secretion in comparison to their Cluster 3 counterparts, who were identified by their elevated NP macrophage expression (all adjusted P < 0.05). Conclusion: Our work elucidates the multifaceted interplay of patient factors, innate immunity, and inflammasome responses in lung tissues subjected to ex vivo H3N2 IAV exposure, reflecting real-world lower respiratory tract infections. While these findings provide a foundation for tailored therapeutic strategies, supplementary studies are requisite for thorough validation and refinement.

The dual role of innate immunity during influenza

Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19

Immune Cellular Networks Underlying Recovery from Influenza Virus Infection in Acute Hospitalized Patients

In-concert Immune Dynamics During Natural Influenza Virus Infection and Recovery in Acute Hospitalized Patients

Bioinformatic analysis of PD 1 checkpoint blockade responsive immune microenvironment in severe influenza infection

Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs

Innate immunity to influenza virus infection

A Game of Infection – Song of Respiratory Viruses and Interferons

Interaction among inflammasome, PANoptosise, and innate immune cells in infection of influenza virus: Updated review

New fronts emerge in the influenza cytokine storm

Impact of patient characteristics on innate immune responses and inflammasome activation in ex vivo human lung tissues infected with influenza A virus

Defining the balance between optimal immunity and immunopathology in influenza virus infection

Taking AIM at Influenza: The Role of the AIM2 Inflammasome

Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1

Specific and Nonspecific Effects of Influenza Vaccines

Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection

An Update on Innate Immune Responses during SARS-CoV-2 Infection

“The Good, the Bad and the Ugly”: Interplay of Innate Immunity and Inflammation

Influenza: old and new threats

Rebalancing Viral and Immune Damage versus Tissue Repair Prevents Death from Lethal Influenza Infection

Balancing Immune Protection and Immune Pathology by CD8+ T-Cell Responses to Influenza Infection